ArticleEvidence-based complementary and alternative medicine : eCAM2023

Retracted: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.

Evidence-Based Complementary And Alternative MedicinePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.